Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001683168-19-002123)

Filing Details

Accession Number:: 0001683168-19-002123
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-07-05 16:13:12
Reporting Period:: 2019-05-29

Accepted Time:: 2019-07-05 16:13:12
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1516079	Us-China Biomedical Technology Inc.	UCBB	Services-Advertising Agencies (7311)	274479356

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1713491	China Israel Biotechnology Co. Ltd	21F, Hualing Building, 111 Furong Road Changsha Hunan Province, China F4 410000		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-05-29	4,290,000	$214,500.00	10,922,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrant	Acquisiton	2019-05-29	10,725,000	$0.05	10,725,000	$0.05

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
10,725,000	2019-05-24	2020-11-24	No	4	P	Direct

Footnotes

On May 29, 2019, the Reporting Person acquired 4,290,000 units at purchase price of $0.05 per share. Each single Unit consists of one (1) share of common stock of the Company and two and one half (2.5) warrants (collectively the "Units"), which shall be exercisable for 18 months at $0.05 per share (the "Warrants").